Evgen Pharma   Report issue

For profit Phase 1 Phase 2
Founded: Wilmslow United Kingdom (2007)
Status: Left NME R&D (2021)

Organization Overview

First Clinical Trial
2012
NCT01948362
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2016

Timeline

NOW
  • Now